<DOC>
	<DOCNO>NCT02516319</DOCNO>
	<brief_summary>The purpose study 1 ) determine feasibility use Cardiox Liver Function Assessment System ( LFA ) measure indocyanine green ( ICG ) clearance ; 2 ) determine adequate dose base LFA technology 3 ) determine adequate time period LFA determination .</brief_summary>
	<brief_title>Liver Function Assessment - Feasibility Dosing Study</brief_title>
	<detailed_description>Four cohort subject enrol . The fist two cohort receive fix dos ICG dye ( 2.5 mg , 5.0 mg , 7.5 mg , 10.0 mg ) follow 20 minute LFT monitoring . The final two cohort receive weight base dos ICG dye ( 0.1 mg/kg , 0.5 mg/kg ) follow 20 minute LFT monitoring . Additionally final two cohort serial blood draw ICG dose 5 , 10 , 15 20 minute post ICG dose .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<criteria>Male female subject , age 18 75 year , inclusive Informed consent documentation understood sign . Known allergy sensitivity ICG iodide contrast dye Pregnant woman nurse baby</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>